OTC

The growth strategy undertaken over the last few years is impressive to say the least. That the company has improved EBITDA from FY2015 of $4.3 million to FY 2016 of $15.2 million underlines this. Due to a repositioning of focus to the building of a national surveying business along with improved margins in infrastructure projects undertaken and synergies gained during the acquisition processes undertaken to date, it isn't hard to see the underlying reasons for the predicted growth in EBITDA towards $25-30 million (see July investor presentation) being achieved or even exceeded in the short to medium term.
At the time of that report @) 23 cps the market cap was $61 million. That equates to about 4 months revenue and 4 x EBITDA. It wasn't hard to see shares had to move upwards. At recent levels of 31 cps market cap stands at $82 million. Once the predicted revenue and EBITDA materialise 31 cps will seem a distant memory. Even at 50 cps market cap stands at less than a year's revenue given the prediction is achieved.

Of course a large EBITDA should result in share dividends and once this is achieved OTC will become a necessary part of most fund managers portfolios. What could be more essential for fund portfolios than an investment in the future infrastructure growth, underpinning Australia's advance, achieved through a highly profitable company. Roll on the growth strategy and OTC won't be sub $1 too long into the future.